SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-021260
Filing Date
2023-03-27
Accepted
2023-03-27 17:28:43
Documents
1
Period of Report
2023-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6674
  Complete submission text file 0001209191-23-021260.txt   8072
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GAIN THERAPEUTICS, INC. 4800 HAMPDEN LANE, SUITE 200 BETHESDA MD 20814
Business Address
Calabrese Salvatore (Reporting) CIK: 0001851958 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40237 | Film No.: 23765539